Evidence map›Paper›PMID 34460332›Full record

SynthesisJournal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

Evidence-Based Recommendations for Nurse Monitoring and Management of Immunotherapy-Induced Cytokine Release Syndrome: A Systematic Review from the Children's Oncology Group.

Emily K Browne, Emily Daut, Monica Hente, Kelly Turner, Katherine Waters, Elizabeth A Duffy

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Emily K BrowneTransition Oncology Program, 547309St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-2098-365X
Emily DautSiteman Kids, 547309St. Louis Children's Hospital-Washington University Physicians, St. Louis, MO, USA.
Monica HenteSiteman Kids, 547309St. Louis Children's Hospital-Washington University Physicians, St. Louis, MO, USA.
Kelly Turner60081Perth Children's Hospital, Nedlands, Western Australia, USA.
Katherine Waters1862Boston Children's Hospital, Boston, MA, USA.
Elizabeth A Duffy16121University of Michigan School of Nursing, Ann Arbor, MI, USA.
St. Louis Children's Hospital · USBoston Children's Hospital · USPrincess Margaret Hospital for Children · AUSt. Jude Children's Research Hospital · USUniversity of Michigan · US

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
NCI NIH HHS U10 CA180886
6 · The paper itself

Abstract

Children with B-precursor acute lymphoblastic leukemia and B-cell lymphoma, particularly those with relapsed or refractory disease, are increasingly enrolled on phase II and phase III clinical trials studying immunotherapies. These therapeutic agents may be associated with a high risk of cytokine release syndrome (CRS), and nurses lack standardized guidelines for monitoring and managing patients with CRS. Six studies and one clinical practice guideline were included in this systematic review that examined the evidence of CRS following administration of chimeric antigen receptor T-cell therapy or the bi-specific T-cell engager antibody, blinatumomab. Six nursing practice recommendations (five strong, one weak) were developed based on low or very low-quality evidence: three reflect preinfusion monitoring, one focuses on monitoring during and postinfusion, and three pertain to the nurse's role in CRS management.

Indexed as

Cytokine Release SyndromePrecursor Cell Lymphoblastic Leukemia-LymphomaChildHumansImmunotherapyImmunotherapy, Adoptivechimeric antigen receptor T-cell therapycytokinesguidelinesimmunotherapy

Identifiers

PMID34460332
PMCPMC8822185
OpenAlexW3197710357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.